WSR 14-02-049

INTERPRETIVE OR POLICY STATEMENT

[Filed December 23, 2013, 3:42 p.m.]

In accordance with RCW 34.05.230(12), following is a list of policy and interpretive statements issued by the health care authority (HCA).

Document Title: Provider Notice #13-112.

Subject: Prescription Drug Medicaid Provider Guide.

Effective for dates of service on and after January 1, 2014, the medicaid program of HCA will pay for hemophilia and von Willebrand-related products [on] a fee-for-service basis for all medicaid clients, including those enrolled in an agency contracted managed care organization.

For additional information, contact Amber Lougheed, HCA, P.O. Box 45504, phone (360) 725-1349, TDD/TTY 1-800-848-5429, fax (360) 586-9727, e-mail amber.lougheed@hca.wa.gov, web site http://www.hca.wa.gov/.